Key stats
About IQ Global Equity R&D Leaders ETF
Expense ratio
0.18%
Home page
Inception date
Feb 8, 2022
WRND seeks exposure to innovative companies that are consistently reinvesting into their research and development activities, whilst exhibiting strong growth potential. It focuses on large- and mid-cap companies around the world, with at least 40% of its net assets invested in foreign countries. Selection begins with the components of the FTSE All-World Index, the parent index, where a total of 200 securities are made constituents of the underlying index. These securities are those with the highest reported one year dollar amount of research and development spending, intended for the innovation and expansion of present capabilities for revenue increase. Constituent weighting is also based on the same sense, highlighting actual fundamentals instead of future estimates, with individual capping at 5%. The index is reconstituted and rebalanced quarterly. WRND launched alongside LRND and MRND to round out IndexIQs growth ETF equity suite.
Classification
What's in the fund
Exposure type
Health Technology
Technology Services
Electronic Technology
Consumer Durables
Stock breakdown by region